Q4F-28668-04740
2 vaccinations
1 coded response
5 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 750 / TX
- Registered
- 2021-01-30
- Relationship
- Self
- Race
- Asian
- Ethnicity
- N/A
Timeline
-
2021-01-05
Dose 1 — Pfizer-BioNTech
-
2021-01-26
Dose 2 — Pfizer-BioNTech
-
2021-01-30
Registered in v-safe
- 2021-01-30
- 2021-02-02
- 2021-02-10
-
2021-02-26
Survey response — day 28, dose 2MedDRA: Blood glucose increased, Herpes zoster — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Increased blood glucose, Shingles like symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-26
Report sent to call center — day 28, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-04
- 2021-03-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-05 | Pfizer-BioNTech | |
| 2 | 2021-01-26 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 4 — day 28, dose 2
Symptoms: Increased blood glucose, Shingles like symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Blood glucose increased | ✓ | ✓ | ✓ |
| SD | Herpes zoster | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release